Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.03
RAD's Cash to Debt is ranked lower than
55% of the 501 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.70 vs. RAD: 0.03 )
RAD' s 10-Year Cash to Debt Range
Min: 0   Max: 0.13
Current: 0.03

0
0.13
Equity to Asset -0.30
RAD's Equity to Asset is ranked lower than
56% of the 501 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.44 vs. RAD: -0.30 )
RAD' s 10-Year Equity to Asset Range
Min: -0.38   Max: 0.47
Current: -0.3

-0.38
0.47
Interest Coverage 1.70
RAD's Interest Coverage is ranked lower than
56% of the 343 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.64 vs. RAD: 1.70 )
RAD' s 10-Year Interest Coverage Range
Min: 0.02   Max: 4.75
Current: 1.7

0.02
4.75
F-Score: 5
Z-Score: 2.82
M-Score: -2.73
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) 2.83
RAD's Operating margin (%) is ranked higher than
68% of the 477 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.80 vs. RAD: 2.83 )
RAD' s 10-Year Operating margin (%) Range
Min: -8.84   Max: 6.03
Current: 2.83

-8.84
6.03
Net-margin (%) 0.98
RAD's Net-margin (%) is ranked higher than
62% of the 477 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.36 vs. RAD: 0.98 )
RAD' s 10-Year Net-margin (%) Range
Min: -11.09   Max: 7.37
Current: 0.98

-11.09
7.37
ROA (%) 3.59
RAD's ROA (%) is ranked higher than
71% of the 477 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.41 vs. RAD: 3.59 )
RAD' s 10-Year ROA (%) Range
Min: -35.01   Max: 18.22
Current: 3.59

-35.01
18.22
ROC (Joel Greenblatt) (%) 19.83
RAD's ROC (Joel Greenblatt) (%) is ranked higher than
75% of the 476 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.19 vs. RAD: 19.83 )
RAD' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -45.25   Max: 19.83
Current: 19.83

-45.25
19.83
Revenue Growth (%) -3.00
RAD's Revenue Growth (%) is ranked higher than
54% of the 439 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.90 vs. RAD: -3.00 )
RAD' s 10-Year Revenue Growth (%) Range
Min: -16   Max: 15.1
Current: -3

-16
15.1
EBITDA Growth (%) 24.50
RAD's EBITDA Growth (%) is ranked higher than
95% of the 399 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.00 vs. RAD: 24.50 )
RAD' s 10-Year EBITDA Growth (%) Range
Min: -15.3   Max: 30.5
Current: 24.5

-15.3
30.5
» RAD's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

RAD Guru Trades in Q3 2013

Ken Fisher 14,510 sh (New)
Ray Dalio 96,000 sh (New)
Louis Moore Bacon 180,000 sh (New)
Jeremy Grantham 141,338 sh (New)
Paul Tudor Jones 1,620,500 sh (+547.68%)
Steven Cohen 4,270,739 sh (+141.89%)
Pioneer Investments Sold Out
John Keeley Sold Out
Joel Greenblatt 1,959,474 sh (-8.3%)
David Einhorn 16,160,000 sh (-20%)
Jim Simons 4,211,600 sh (-47.89%)
» More
Q4 2013

RAD Guru Trades in Q4 2013

Pioneer Investments 23,609 sh (New)
John Burbank 31,165 sh (New)
John Hussman 1,200,000 sh (New)
Ray Dalio 132,400 sh (+37.92%)
Steven Cohen 4,772,979 sh (+11.76%)
Steven Cohen 300,000 sh (unchged)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
Jeremy Grantham 140,092 sh (-0.88%)
Ken Fisher 11,500 sh (-20.74%)
David Einhorn 12,120,000 sh (-25%)
Joel Greenblatt 977,915 sh (-50.09%)
Paul Tudor Jones 91,000 sh (-94.38%)
» More
Q1 2014

RAD Guru Trades in Q1 2014

Jim Simons 1,593,000 sh (New)
George Soros 2,043,700 sh (New)
Paul Tudor Jones 2,104,420 sh (+2212.55%)
Ray Dalio 1,085,900 sh (+720.17%)
Ken Fisher 12,100 sh (+5.22%)
Jeremy Grantham Sold Out
Pioneer Investments Sold Out
John Burbank 26,509 sh (-14.94%)
John Hussman 1,000,000 sh (-16.67%)
David Einhorn 5,511,246 sh (-54.53%)
Steven Cohen 1,126,005 sh (-76.41%)
Joel Greenblatt 158,445 sh (-83.8%)
» More
Q2 2014

RAD Guru Trades in Q2 2014

Ken Fisher 10,350 sh (-14.46%)
» More
» Details

Insider Trades

Latest Guru Trades with RAD

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
George Soros 2014-03-31 New Buy0.13%$5.04 - $6.92 $ 6.6810%2043700
Joel Greenblatt 2014-03-31 Reduce -83.8%0.1%$5.04 - $6.92 $ 6.6810%158445
Ray Dalio 2014-03-31 Add 720.17%0.05%$5.04 - $6.92 $ 6.6810%1085900
John Hussman 2013-12-31 New Buy0.43%$4.83 - $6.11 $ 6.6825%1200000
Joel Greenblatt 2013-12-31 Reduce -50.09%0.15%$4.83 - $6.11 $ 6.6825%977915
John Burbank 2013-12-31 New Buy0.01%$4.83 - $6.11 $ 6.6825%31165
Ray Dalio 2013-12-31 Add 37.92%$4.83 - $6.11 $ 6.6825%132400
John Keeley 2013-09-30 Sold Out 0.01%$2.74 - $4.94 $ 6.6896%0
Ray Dalio 2013-09-30 New Buy$2.74 - $4.94 $ 6.6896%96000
Ray Dalio 2013-06-30 Sold Out 0.02%$1.71 - $3.15 $ 6.68156%0
John Keeley 2013-06-30 New Buy0.01%$1.71 - $3.15 $ 6.68156%160000
Joel Greenblatt 2013-03-31 Add 147.43%0.13%$1.29 - $1.94 $ 6.68307%2291579
Ray Dalio 2013-03-31 Add 304.18%0.01%$1.29 - $1.94 $ 6.68307%1034700
Joel Greenblatt 2012-12-31 Add 1530.62%0.07%$0.97 - $1.44 $ 6.68502%926161
Ray Dalio 2012-12-31 Reduce -58.3%0.01%$0.97 - $1.44 $ 6.68502%256000
Ray Dalio 2012-09-30 New Buy0.01%$1.12 - $1.45 $ 6.68434%613900
Joel Greenblatt 2012-09-30 New Buy$1.12 - $1.45 $ 6.68434%56798
Richard Perry 2012-03-31 Sold Out 1.1%$1.25 - $2.05 $ 6.68351%0
Joel Greenblatt 2011-09-30 Sold Out 0.0057%$0.9862 - $1.35 $ 6.68481%0
George Soros 2011-09-30 Sold Out 0.0002%$0.9862 - $1.35 $ 6.68481%0
Richard Perry 2011-06-30 Add 56.24%0.2%$1.01 - $1.28 $ 6.68502%14190000
Joel Greenblatt 2011-06-30 Reduce -55.54%0.01%$1.01 - $1.28 $ 6.68502%31175
George Soros 2011-06-30 Reduce -72.05%$1.01 - $1.28 $ 6.68502%10900
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Rite Aid Corp

Weekly Insider Sells Highlight: RAD, KOS, SNDK, AFOP
According to GuruFocus Insider Data, the largest insider sells during the past week were: Rite Aid Corp., Kosmos Energy Ltd., SanDisk Corp., Crown Holdings Inc. and Alliance Fiber Optic Products Inc. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 51.30
RAD's P/E(ttm) is ranked higher than
58% of the 517 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.40 vs. RAD: 51.30 )
RAD' s 10-Year P/E(ttm) Range
Min: 3.17   Max: 6590
Current: 51.3

3.17
6590
P/S 0.25
RAD's P/S is ranked higher than
80% of the 517 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.47 vs. RAD: 0.25 )
RAD' s 10-Year P/S Range
Min: 0.01   Max: 0.32
Current: 0.25

0.01
0.32
PFCF 21.40
RAD's PFCF is ranked higher than
80% of the 517 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 48.35 vs. RAD: 21.40 )
RAD' s 10-Year PFCF Range
Min: 1.88   Max: 80.83
Current: 21.4

1.88
80.83
EV-to-EBIT 17.42
RAD's EV-to-EBIT is ranked higher than
67% of the 517 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 15.68 vs. RAD: 17.42 )
RAD' s 10-Year EV-to-EBIT Range
Min: 9.6   Max: 618
Current: 17.42

9.6
618
PEG 2.30
RAD's PEG is ranked higher than
82% of the 517 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.78 vs. RAD: 2.30 )
RAD' s 10-Year PEG Range
Min: 2.3   Max: 13.74
Current: 2.3

2.3
13.74
Current Ratio 1.64
RAD's Current Ratio is ranked higher than
84% of the 504 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.21 vs. RAD: 1.64 )
RAD' s 10-Year Current Ratio Range
Min: 0.81   Max: 3.28
Current: 1.64

0.81
3.28
Quick Ratio 0.50
RAD's Quick Ratio is ranked higher than
62% of the 504 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.68 vs. RAD: 0.50 )
RAD' s 10-Year Quick Ratio Range
Min: 0.13   Max: 0.78
Current: 0.5

0.13
0.78

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 2.60
RAD's Price/Median PS Value is ranked lower than
54% of the 517 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.11 vs. RAD: 2.60 )
RAD' s 10-Year Price/Median PS Value Range
Min: 0.09   Max: 9.14
Current: 2.6

0.09
9.14
Earnings Yield (Greenblatt) 5.80
RAD's Earnings Yield (Greenblatt) is ranked higher than
63% of the 486 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.80 vs. RAD: 5.80 )
RAD' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.2   Max: 10.4
Current: 5.8

0.2
10.4
Forward Rate of Return (Yacktman) 1.04
RAD's Forward Rate of Return (Yacktman) is ranked higher than
64% of the 349 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.61 vs. RAD: 1.04 )
RAD' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -78.3   Max: 35.3
Current: 1.04

-78.3
35.3

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers
Compare:SHDMF, APNHF, GNC, JCOUF, PMC » details
Traded in other countries:RTA.Germany
Rite Aid Corporation, a Delaware corporation was incorporated in 1968. It operates a retail drugstore chain in the United States. It operates its drugstores in 31 states across the country and in the District of Columbia. As of March 3, 2012, it operated 4,623 stores. The Company sells prescription drugs and an assortment of other merchandise, which it calls 'front end' products. Front end products include over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise and numerous other convenience products. The Company attempts to distinguish its stores from other national chain drugstores, in part, through its wellness + loyalty program, private brands and its strategic alliance with GNC, a retailer of vitamin and mineral supplements. The retail drugstore industry is competitive. It competes with retail drugstore chains, independently owned drugstores, supermarkets, mass merchandisers, discount stores, dollar stores and mail order pharmacies. The Company's business is subject to federal, state, and local government laws, regulations and administrative practices. It must comply with numerous provisions regulating health and safety, equal employment opportunity, minimum wage and licensing for the sale of drugs, alcoholic beverages, tobacco and other products.
» More Articles for RAD

Headlines

Articles On GuruFocus.com
Is Walgreen Set For A Better 2014? Jul 28 2014 
Looking beyond Walgreen’s Quarter Jul 21 2014 
Rite Aid Corporation is Destined for Greatness Jul 07 2014 
Here's Why Rite Aid and Walgreens Are Still Solid Picks May 29 2014 
Rite Aid Corporation May Be a Buy: More Upside Expected May 20 2014 
J. C. Penney: Embrace the Fear with the Right Investment Thesis May 03 2014 
Weekly Insider Sells Highlight: RAD, KOS, SNDK, AFOP Apr 29 2014 
Walgreen Co. (WAG) Dividend Stock Analysis Mar 28 2014 
Weekly CEO Sells Highlight: Rite Aid Corporation, Golub Capital BDC Inc, Amazon.com Inc, and America Feb 23 2014 
Weekly CFO Sells Highlight: RAD, SCHW, ATU, HOLX Oct 20 2013 

More From Our Partners
David Einhorn's Hedge Fund Sells Off Shares Of Rite Aid Jul 28 2014 - BENZINGA

More From Other Websites
Why Rite Aid (RAD) Stock Is Up Today Jul 30 2014
Plug in to Rite Aid for This Year’s Trendiest Back-to-School Needs Jul 30 2014
Plug in to Rite Aid for This Year’s Trendiest Back-to-School Needs Jul 30 2014
RITE AID CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements... Jul 29 2014
Rite Aid (RAD) Is Water-Logged And Getting Wetter Today Jul 28 2014
Why Rite Aid (RAD) Stock Is Down Today Jul 28 2014
How Does Rite Aid Measure Up Vs. Walgreens in Stock Price, Sales? Jul 25 2014
CFO Moves: Rite Aid, Roundy's, Mothercare Jul 25 2014
Einhorn bought Lam Research shares, sold Rite Aid last quarter Jul 25 2014
Cardtronics, Inc. -- Moody's lowers Cardtronics' Speculative Grade Liquidity Rating to SGL-2 Jul 24 2014
Darren Karst Appointed Rite Aid Executive Vice President and Chief Financial Officer Jul 24 2014
Darren Karst Appointed Rite Aid Executive Vice President and Chief Financial Officer Jul 24 2014
Cardtronics to Acquire Welch ATM, Boost National Presence Jul 23 2014
CVS Minute Clinic experience is efficient and effective, but EHR interoperability isn't Jul 21 2014
Rite Aid: Work On Growth Initiatives Key To Earning A Bullish Thesis Jul 19 2014
Rite Aid: Take Advantage Of A Myopic Market Jul 17 2014
U.S. retailers' June same-store sales Jul 10 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide